3 Results for "

photosensitive diseases

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "photosensitive diseases" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-17484
CAS No.: 99464-64-9
Synonyms: CP 65703
Target:  

Drug Derivative

Research Areas:  

Inflammation/Immunology

Ampiroxicam is an orally active prodrug of non-steroidal anti-inflammatory drug (NSAID). Ampiroxicam inhibits paw swelling in adjuvant-induced arthritis and acute inflammation models, and suppresses phenylbenzoquinone-induced stretching responses in mice. Ampiroxicam is rapidly and completely converted to Piroxicam (HY-B0253) via non-specific esterases and first-pass metabolism. Ampiroxicam induces contact hypersensitivity and photosensitivity reactions through photoproducts generated by UVA. Ampiroxicam can be used in research related to photosensitivity, adjuvant-induced arthritis, rheumatism, osteoarthritis and other inflammatory diseases .
loading...
    loading...
Cat. No.: HY-17484R
CAS No.: 99464-64-9
Synonyms: CP 65703 (Standard)
Target:  

Reference Standards

Research Areas:  

Inflammation/Immunology

Ampiroxicam (Standard) is the analytical standard of Ampiroxicam. This product is intended for research and analytical applications. Ampiroxicam is an orally active prodrug of non-steroidal anti-inflammatory drug (NSAID). Ampiroxicam inhibits paw swelling in adjuvant-induced arthritis and acute inflammation models, and suppresses phenylbenzoquinone-induced stretching responses in mice. Ampiroxicam is rapidly and completely converted to Piroxicam (HY-B0253) via non-specific esterases and first-pass metabolism. Ampiroxicam induces contact hypersensitivity and photosensitivity reactions through photoproducts generated by UVA. Ampiroxicam can be used in research related to photosensitivity, adjuvant-induced arthritis, rheumatism, osteoarthritis and other inflammatory diseases.
loading...
    loading...
Cat. No.: HY-125055A
CAS No.: 1417342-67-6
Target:  

Melanocortin Receptor

Research Areas:  

Metabolic Disease

CD08108 is a selective MC1R full agonist with an EC50 of 70 nM against hMC1R. CD08108 participates in the melanogenesis process. CD08108 promotes cell proliferation. CD08108 can be used in studies related to vitiligo, subcutaneous diseases and photosensitive diseases .
loading...
    loading...